Menu
Recruiting NCT07689357

Cervical Ripening Balloon, 3 Hours vs 12 Hours Placement

No phase Interventional Labor Induction Cervical Ripening and Induction of Labor

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
The protocol lists: Cook Cervical Ripening Balloon 3 hours, Cook Cervical Ripening Balloon 12 hours.
Who it may be relevant to
Registry conditions: Labor Induction, Cervical Ripening and Induction of Labor. Basic parameters: 18 years — 45 years · Female.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
Israel
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Official title

Comparison of Labor Induction With Cervical Ripening Balloon, 3 Hours vs 12 Hours Placement: a Randomized Controlled Trail

Overview

The goal of this clinical trial is to learn if a shorter duration of cervical ripening balloon (CRB) placement can reduce the time to delivery in pregnant women undergoing induction of labor. The main questions it aims to answer are: Does placing the cervical ripening balloon for 3 hours or less result in a shorter interval from insertion to delivery compared to the standard 12-hour placement? Does a shorter 3-hour balloon placement lead to better pregnancy outcomes, fewer complications, and lower maternal discomfort? Researchers will compare a group of participants who have the balloon removed after 3 hours to a control group who have the balloon removed after 12 hours to see if the shorter duration decreases the overall time to delivery. Participants will: Sign an informed consent and be randomized into one of the two groups (3 hours vs. 12 hours). Undergo the standard procedure of a double-lumen Cook cervical ripening balloon insertion. Have the balloon removed after approximately 3 hours or 12 hours depending on their assigned group. Proceed with amniotomy or Pitocin use at the discretion of the labor and delivery physician. Complete a Birth Satisfaction Scale questionnaire and have their maternal and neonatal health outcomes tracked from the hospital's database.

Interventions

  • Device Cook Cervical Ripening Balloon 3 hours
    Use of a transcervical balloon catheter for pre-induction cervical ripening. The catheter is inserted through the cervix, the balloon(s) inflated with sterile saline. The device remains in place for 3 hours.
  • Device Cook Cervical Ripening Balloon 12 hours
    Use of a transcervical balloon catheter for pre-induction cervical ripening. The catheter is inserted through the cervix, the balloon(s) inflated with sterile saline. The device remains in place for 12 hours.

Primary outcome measures

  • Insertion-to-Delivery Time Interval [Time frame: From the time of balloon insertion up to delivery (approximately 48 hours).]
Secondary outcome measures (5)
  • Mode of Delivery [Time frame: At the time of delivery.]
  • Time to Active Phase and Second Stage of Labor [Time frame: From balloon insertion up to delivery, assessed up to 48 hours after balloon insertion.]
  • Maternal Complications [Time frame: From balloon insertion up to 48 hours postpartum.]
  • Adverse Neonatal Outcomes [Time frame: From birth up to newborn discharge or 7 days of life.]
  • Duration of Hospitalization [Time frame: From admission for induction up to hospital discharge (approximately 3-5 days).]

Eligibility criteria

Inclusion criteria

  • Nulliparous or multiparous pregnant women.
  • Gestational age between 37 0/7 and 41 6/7 weeks of gestation.
  • Maternal age between 18 and 45 years.
  • Participant has provided signed informed consent.

Exclusion criteria

  • Presence of any contraindications for vaginal delivery.
  • Multifetal gestation.
  • Rupture of membranes prior to balloon insertion.
  • Favorable cervix, defined as a Bishop score greater than 6.
  • Cervical dilation greater than 2 cm.
  • Previous cesarean delivery or any other prior major uterine surgery.

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: No

Study design

Allocation
Randomized
Model
Parallel assignment
Masking
Open label
Primary purpose
Treatment

Study locations

Israel · 1 center
  • Rambam Health Care Campus — Haifa

Identifiers

NCT: NCT07689357 · 0602-21-RMB

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗